Physician

Mohammad Raihan Azad, MD

According to 2025 Medicare claims, Mohammad Azad, MD (NPI: 1356699904) practices endocrinology in the Greenville, NC market, with the plurality of this provider's patient population coming from Pitt, NC. This provider's primary affiliated billing organization is PHYSICIANS EAST, P.A. (NPI: 1598761967; TIN: 561968491) and primary practice location at 27834-5194. Azad is affiliated with the Rochester Regional Health ACO, Inc. (ACO ID: A3476) and Aledade A4548 NC Legacy MSSP Enhanced (ACO ID: A4548), participating under the MSSP model.

Azad's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 767 traditional Medicare patients, billed 10,138 HCPCS/CPT codes, and received $242,152 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 7,209 prescription claims across 761 beneficiaries totaling $4,276,889 in drug costs, led by Ozempic (Semaglutide). DME data shows 856 claims. Open Payments data shows 45 records totaling $815. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $17,379 to $242,152. Similarly, Part D prescription costs have moved sharply higher in recent years, from $12,403 to $4,276,889. For DME billing, reported payments moved sharply higher in recent years, from $974 to $264,843.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	97	295	$17,379
2016	N/R	N/R	N/R
2017	143	703	$30,292
2018	475	4,038	$123,201
2019	660	7,643	$179,132
2020	729	20,619	$289,020
2021	760	17,153	$284,342
2022	763	13,778	$248,444
2023	703	14,473	$263,078
2024	767	10,138	$242,152

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	64	145	$12,403
2016	44	262	$44,782
2017	79	334	$72,536
2018	231	1,631	$588,244
2019	357	3,043	$1,523,603
2020	492	4,269	$2,424,406
2021	562	5,340	$3,272,492
2022	609	5,818	$3,836,623
2023	664	6,329	$4,637,547
2024	761	7,209	$4,276,889

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	20	71	$1,278
2018	61	161	$9,050
2019	152	452	$62,948
2020	241	749	$132,044
2021	260	1,076	$190,920
2022	254	1,135	$227,934
2023	218	1,148	$230,858
2024	223	856	$280,329

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	435	729	$88
77080	Dxa bone density measurement of hip, pelvis, spine	252	252	$18
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	335	454	$12
83036	Hemoglobin a1c level	227	430	$9
36415	Insertion of needle into vein for collection of blood sample	262	317	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	800	32,782	$1,071,291
Soliqua 100-33	Insulin Glargine/Lixisenatide	365	13,584	$377,869
Mounjaro	Tirzepatide	242	8,204	$301,862
Farxiga	Dapagliflozin Propanediol	382	16,159	$293,764
Jardiance	Empagliflozin	234	10,353	$196,860

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	113	538	$222,616
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	12	40	$17,862
E0784	External ambulatory infusion pump, insulin	Y	N/R	45	$14,991
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	16	52	$12,564
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	33	33	$6,518

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	45	$815	Corcept Therapeutics
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mohammad Raihan Azad, MD?

Tedicare shows public-source Medicare data for Mohammad Raihan Azad, MD (NPI 1356699904), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mohammad Raihan Azad, MD have ACO affiliation data?

Mohammad Raihan Azad, MD is shown with ACO affiliation data for Rochester Regional Health ACO, Inc. (MSSP, ACO ID A3476) and Aledade A4548 NC Legacy MSSP Enhanced (MSSP, ACO ID A4548).

What billing organization is linked to Mohammad Raihan Azad, MD?

Mohammad Raihan Azad, MD is linked to PHYSICIANS EAST, P.A. (billing NPI 1598761967) in the available physician profile data.

Does Mohammad Raihan Azad, MD have Open Payments data?

Mohammad Raihan Azad, MD has 45 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.